Skip to main content
Richard Hengel, MD, Infectious Disease, Atlanta, GA

RichardLowellHengelMDFACP

Infectious Disease • Atlanta, GA

Physician

Join to view full profile

Dr. Hengel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hengel's full profile

Already have an account?

  • Office

    275 Collier Road, Nw
    Suite 450
    Atlanta, GA 30309
    Phone+1 404-351-8873
    Fax+1 404-355-6165

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Infectious Disease, 1994 - 1998
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1991 - 1993
  • University of Alberta
    University of AlbertaClass of 1988

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1994 - 2025
  • DC State Medical License
    DC State Medical License 1998 - 2006
  • OH State Medical License
    OH State Medical License 1992 - 1994
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2011

Publications & Presentations

PubMed

Press Mentions

  • Bezlotoxumab (Zinplava)for Prevention of Recurrent C. Difficile Infection
    Bezlotoxumab (Zinplava)for Prevention of Recurrent C. Difficile InfectionOctober 7th, 2018
  • Ferring to Present New Data Analyses at IDWeek 2023 for REBYOTA® (Fecal Microbiota, Live – Jslm), the First and Only Single-Dose, FDA Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile Infection
    Ferring to Present New Data Analyses at IDWeek 2023 for REBYOTA® (Fecal Microbiota, Live – Jslm), the First and Only Single-Dose, FDA Approved Microbiome-Based Treatment for the Prevention of Recurrent C. Difficile InfectionSeptember 24th, 2023

Professional Memberships

Dr. Richard Hengel, Dr. Richard Hengel, MD, Dr. R Hengel, Dr. Richard Lowell Hengel